Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.5K
Overview
28.5K
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

965
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
965
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

431
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
431
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

650
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
650
Hypersensitivities01:30

Hypersensitivities

1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Venom Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same author

Guidelines and shared decision-making for disruptive innovations in allergy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K

Venom allergen immunotherapy.

David B K Golden

    Allergy and Asthma Proceedings
    |July 12, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Venom immunotherapy (VIT) effectively prevents severe allergic reactions to insect stings. VIT is recommended based on clinical history and allergy tests, with rush regimens offering a safe and efficient initial treatment approach.

    More Related Videos

    Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
    05:27

    Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

    Published on: October 6, 2023

    3.2K
    Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
    10:25

    Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

    Published on: November 3, 2014

    33.8K

    Related Experiment Videos

    Last Updated: Sep 5, 2025

    Basophil Activation Test for Allergy Diagnosis
    07:22

    Basophil Activation Test for Allergy Diagnosis

    Published on: May 31, 2021

    8.5K
    Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
    05:27

    Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

    Published on: October 6, 2023

    3.2K
    Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
    10:25

    Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

    Published on: November 3, 2014

    33.8K

    Area of Science:

    • Allergy and Immunology
    • Toxicology
    • Pharmacology

    Background:

    • Hymenoptera venom immunotherapy (VIT) is a cornerstone treatment for preventing severe allergic reactions to insect stings.
    • Not all patients stung by insects require VIT; careful risk assessment is crucial.
    • Understanding reaction severity and risk factors guides treatment decisions.

    Purpose of the Study:

    • To review the efficacy and safety of venom immunotherapy for Hymenoptera stings.
    • To outline criteria for initiating and discontinuing VIT.
    • To highlight important considerations for patient management during VIT.

    Main Methods:

    • Review of clinical guidelines and evidence regarding VIT.
    • Analysis of risk factors for severe reactions and anaphylaxis.
    • Evaluation of different VIT administration regimens (e.g., rush vs. traditional).

    Main Results:

    • VIT is highly effective in preventing large local, systemic allergic, and anaphylactic reactions.
    • Cutaneous or large local reactions typically do not necessitate VIT.
    • Rush VIT regimens are as safe or safer than traditional regimens for initial treatment.
    • VIT has a low incidence of systemic reactions; injection-site reactions are common but not predictive of systemic events.
    • Screening for baseline serum tryptase and mast cell disorders is recommended for patients undergoing VIT.

    Conclusions:

    • Venom immunotherapy is a safe and effective treatment for preventing severe allergic reactions to Hymenoptera stings.
    • Patient selection, risk stratification, and appropriate regimen choice are key to successful VIT.
    • VIT can often be discontinued after five years, but indefinite treatment may be necessary for high-risk individuals.